drugset / Trial / NCT01385748
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Clonidine Lauriad® to treat chemoradiation therapy induced severe oral mucositis in patients with head and neck cancer.
Timeline
- Start
- 2010-04
- Primary completion
- 2014-10
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clonidine | Other / unclassified | 50 ug | Other |
| Comparator | Clonidine | Other / unclassified | 100 ug | Other |